Iterum Therapeutics ITRMF
ITRMF
$0.00 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Iterum Therapeutics plc (ITRMF) Preferred Stock Liabilities (2017)

Iterum Therapeutics (ITRMF) posted quarterly Preferred Stock Liabilities of $30000.0 for Q4 2017.

Iterum Therapeutics plc (ITRMF) Preferred Stock Liabilities (2017) Analysis & Trends

Iterum Therapeutics' Preferred Stock Liabilities history runs 1 years deep, the most recent figure standing at $30000.0 for Q4 2017.

  • In Q4 2017, Preferred Stock Liabilities changed N/A year-over-year to $30000.0; the TTM figure through Dec 2017 stood at $30000.0 (changed N/A YoY), while the FY2017 annual figure was $30000.0, changed N/A from the prior year.
  • Preferred Stock Liabilities for Q4 2017 stood at $30000.0.
  • The five-year high for Preferred Stock Liabilities was $30000.0 in Q4 2017, with the low at $30000.0 in Q4 2017.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2017 30,000.00